These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 594306)

  • 21. [The familial incidence of various types of hyperlipoproteinaemia (author's transl)].
    Rudas B; Marktl W; Swoboda W
    Wien Klin Wochenschr; 1977 May; 89(11):376-8. PubMed ID: 878478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal study of serum lipids and lipoproteins in normal pregnancy and puerperium.
    Sitadevi C; Patrudu MB; Kumar YM; Raju GR; Suryaprabha K
    Trop Geogr Med; 1981 Sep; 33(3):219-23. PubMed ID: 7314233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid and lipoprotein profile in physiological pregnancy.
    Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
    Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Data control of individual samples in analysis of serum lipids - (I). Concepts of the regression method (author's transl)].
    Todoroki T; Tsukamoto H; Matsumoto K; Kano S; Kanno T
    Rinsho Byori; 1981 Nov; 29(11):1130-5. PubMed ID: 7334667
    [No Abstract]   [Full Text] [Related]  

  • 25. [Plasma lipid concentrations during the healing phase after myocardial infarction (author's transl)].
    Ravens KG; Jipp P
    Med Klin; 1977 Mar; 72(9):343-8. PubMed ID: 840145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
    Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Type distribution of hyperlipoproteinemias in 645 diabetics].
    Möricke R; Marek H; Winiecki P; Mochow P; Bindseil S; Reichert E
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 171-4. PubMed ID: 930175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening methods for hyperlipoproteinemia detecting (author's transl)].
    Odrowaz-Sypniewska G; Szostak W; Chotkowska E
    Przegl Lek; 1978; 35(4-5):448-9. PubMed ID: 211557
    [No Abstract]   [Full Text] [Related]  

  • 31. Neonatal diagnosis of Fredrickson type II hyperlipoproteinaemia.
    Andersen GE
    Postgrad Med J; 1975; 51(8):suppl 93-4. PubMed ID: 215988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids].
    Ose L; Aass B; Christophersen B
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3487-9. PubMed ID: 7491599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipid particles agglutinated in hyperlipidemias with opalescent sera (author's transl)].
    Buxtorf JC; Delplanque B; Baudet MF; Beaumont JL
    Sem Hop; 1979 Jan 18-25; 55(3-4):193-7. PubMed ID: 219528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum lipids levels, lipoprotein phenotypes and analysis of lipoprotein in Italian population group (author's transl)].
    Avogaro P; Cazzolato G; Capri C; Pais M; Trabuio GF
    G Ital Cardiol; 1974; 4(2):237-48. PubMed ID: 4365662
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combined electrophoresis and ultracentrifugation in diagnosis of primary hyperlipidemia].
    Davignon J; Langelier M
    Union Med Can; 1971 Nov; 100(11):2120-8. PubMed ID: 5150698
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis of type III hyperlipoproteinemia: contribution of an air-driven ultracentrifuge associated with an original tube-slicer (author's transl].
    Moulin S; Dewailly P; Sezille G; Fruchart JC
    Ann Biol Clin (Paris); 1979; 37(2):103-5. PubMed ID: 475070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic importance of the analysis of plasmatic lipids].
    Englhardt A
    Minerva Med; 1972 Apr; 63(31):1807-12. PubMed ID: 5025179
    [No Abstract]   [Full Text] [Related]  

  • 38. Carbohydrate metabolism in various types of hyperlipoproteinaemia.
    Romics L; Stützel M; Balázsi I; Varsányi-Nagy M
    Acta Med Acad Sci Hung; 1976; 33(3):225-32. PubMed ID: 1031550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study from Navarra. Hyperlipidemias. Avarage scores and percentiles for lipids and lipoproteins in a population of children and adolescents. Correlation with anthropometric parameters].
    Elcarte López R; Villa-Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzábal Irigoyen M; Sola Mateos A; García Ibero C; Elcarte López T; Ferrer Giménez M; Fontaneda Estíbaliz A
    An Esp Pediatr; 1993 Apr; 38(4):307-15. PubMed ID: 8480942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.